Stability of Cervical Specimens in SurePath Medium for Human Papillomavirus Testing with the Roche cobas 4800 Assay

Comparison of the Cobas 4800 HPV Test and the Seeplex HPV4A ACE with the Hybrid Capture 2 Test

(2013) Eun Young Ki et al.   International Journal of Medical Sciences

Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study

(2012) J. Thomas Cox et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology

(2011) Mark H. Stoler et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Evaluation of HPV-16 and HPV-18 Genotyping for the Triage of Women With High-Risk HPV+ Cytology-Negative Results

(2011) Thomas C. Wright et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Comparison of the Hybrid Capture 2 and cobas 4800 Tests for Detection of High-Risk Human Papillomavirus in Specimens Collected in PreservCyt Medium

(2011) Anita A. Wong et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Clinical Validation of the cobas 4800 HPV Test for Cervical Screening Purposes

(2011) D. A. M. Heideman et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Formaldehyde substitute fixatives: effects on nucleic acid preservation

(2011) C. B. Moelans et al.   JOURNAL OF CLINICAL PATHOLOGY

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study

(2011) Philip E Castle et al.   LANCET ONCOLOGY

Performance of the Aptima High-Risk Human Papillomavirus mRNA Assay in a Referral Population in Comparison with Hybrid Capture 2 and Cytology

(2010) A. Clad et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Clinical Performance of the PreTect HPV-Proofer E6/E7 mRNA Assay in Comparison with That of the Hybrid Capture 2 Test for Identification of Women at Risk of Cervical Cancer

(2010) S. Ratnam et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Aptima HPV E6/E7 mRNA Test Is as Sensitive as Hybrid Capture 2 Assay but More Specific at Detecting Cervical Precancer and Cancer

(2010) S. Ratnam et al.   JOURNAL OF CLINICAL MICROBIOLOGY